Translate

Global Pediatric Proton Therapy Information and Market Trend & Forecast (10 Countries Data), Patients Treated

"Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

-- Global Pediatric Proton Therapy Market has potential of more than US$ 700 Million by 2021. Rising pediatric cancer incidence and technological improvement to treat faster per patient will boost the pediatric proton therapy market globally.

-- United States is the Global Leader in Treating Pediatric Patients with Proton Therapy 
USA has the highest pediatric proton therapy market share but in future it will lose its market share, due to competition from Germany, France, United Kingdom and Japan. Proton Therapy is becoming a preferential choice of treatment as its ability to treat pediatric cancer in a more efficient way, compared to traditional radiotherapy. Proton Therapy has achieved importance in such a short duration of time period, due to its technological advancement Like Intensity-Modulated Proton Therapy (IMPT) and Pencil Beam Technology.          


-- United States Age Group of (1-4) has the highest Cancer Evidence in Pediatric Proton Therapy Market   
The report captures the USA pediatric proton therapy market data on five age groups (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. In these age groups (1-4) Year has highest market.   


-- Ependymoma Cancerous Tumor holds 15 percent market share in USA Pediatric Proton Therapy Market
The report captures 36 Type of Cancer Market & number of pediatric patients in USA. Ependymoma Cancerous Tumor holds the highest market, among all the other 36 pediatric cancer market.    

-- Germany, United Kingdom and France will drive the Europe Pediatric Proton Therapy Market 
Germany holds a significant market share in Global Pediatric Proton Therapy Market. United Kingdom is more concerned about proton therapy especially for pediatric treatment. United Kingdom NHS (National Health Service) used to send massive number of pediatric patients for the proton therapy treatment abroad. Switzerland and France are also developing new proton therapy center. France used to have maximum pediatric proton therapy market share in 2010.

Japan, China & South Korea helping the Proton Therapy Market in Asia to Grow
In Asia, Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China is more focused toward developing 8 proton therapy centers (Under-construction + Planning Phase) to serve their massive population. 


Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated is the 20th report published by Renub Research on Proton Therapy Market. This 330 page report with 287 figures and 7 Tables provides 10 Countries: Pediatric Proton Therapy Market, Proton Therapy Patient Numbers, Cancer Type Markets in USA, Technology being used at these Proton Therapy Centers and Reimbursement Policies. The report also studies the Proton Therapy Sales & Forecast of four companies - IBA, Varian Medical Systems, Mitsubishi and Hitachi.

-- Key Questions Answered in the Report
  • What is the Global Pediatric Proton Therapy Market and its growth potential in Future
  • What is the Number of pediatric patients treated by Proton Beam Therapy worldwide
  • What are the reimbursement policies for Proton Therapy across the world
  • What is the Pediatric Proton Therapy Market in United States and Forecast
  • What is the Number of Pediatric Proton Therapy Patients by age group in United States and Forecast
  • What is the Number of Pediatric Proton Therapy Patients by tumor type in United States and Forecast
  • What is the Pediatric Proton Therapy Market size in Asia (Japan, China and South Korea) and its growth potential in future
  • What is the Number of Pediatric Proton Therapy patients treated in Asia (Japan, China and South Korea)
  • What is the Pediatric Proton Therapy Market in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast
  • What is the Number of Pediatric Proton Therapy Patients in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast
  • What Type of Technology is being used at Proton Therapy Centers


-- Key Companies Proton Therapy Sales Analysis (2010 – 2021) 
  1. IBA
  2. Varian Medical Systems  
  3. Mitsubishi
  4. Hitachi 


-- Countries Pediatric Proton Therapy Market & Number of Patients studied in the Report
  1. United States
  2. United Kingdom  
  3. Switzerland
  4. Germany
  5. France  
  6. Sweden 
  7. Czech Republic
  8. Japan 
  9. Korea 
  10. China 

-- Table of Content
1. Research Findings


2. Global Pediatric Proton Therapy Number of Patients (Actual & Potential)
2.1 Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
2.2 Pediatric Patients with Proton Therapy Potential Numbers & Forecast


3. Global Pediatric Proton Therapy Market (Actual & Potential)
3.1 Pediatric Proton Therapy Market & Forecast
3.2 Pediatric Proton Therapy - Potential Market & Forecast


4. Global Pediatric Proton Therapy Market Share & Forecast
4.1 By Region (Asia, Europe, USA) – Global Pediatric Proton Therapy Market Share
4.2 By Countries – Global Pediatric Proton Therapy Market Share


5. United States Pediatric Proton Therapy Market (Actual & Potential)
5.1 United States Pediatric Proton Therapy Market & Forecast
5.2 United States Potential Pediatric Proton Therapy Market & Forecast


6. USA Pediatric Proton Therapy Market by Age Group
6.1 By Age Group (<1) Year
6.2 By Age Group (1-4) Year
6.3 By Age Group (5-9) Year
6.4 By Age Group (10-14) Year
6.5 By Age Group (15-18) Year


7. USA Pediatric Proton Therapy Patient Number - Actual and Potential
7.1 USA Pediatric Patients Treated with Proton Therapy Numbers & Forecast
7.2 USA Pediatric Patients with Proton Therapy Potential Numbers & Forecast


8. USA Pediatric Proton Therapy Patients Numbers by Age Group
8.1 By Age (<1) Year
8.2 By Age (1- 4) Year
8.3 By Age (5- 9) Year
8.4 By Age (10-14) Year
8.5 By Age (15- 18) Year


9. Tumor Types – USA Pediatrics Proton Therapy Market (2010 – 2021)
9.1 Glioma, Low Grade – Market & Forecast
9.2 Glioma, High Grade – Market & Forecast
9.3 Medulloblastoma – Market & Forecast
9.4 Ependymoma – Market & Forecast
9.5 ATRT – Market & Forecast
9.6 Germinoma, Pure – Market & Forecast
9.7 Germ Cell Tumor – Market & Forecast
9.8 Craniopharyngioma – Market & Forecast
9.9 PNET – Market & Forecast
9.10 Pineoblastoma – Market & Forecast
9.11 Chordoma/Chondrosarcoma – Market & Forecast
9.12 Meningioma – Market & Forecast
9.13 AVM – Market & Forecast
9.14 Adenoma – Market & Forecast
9.15 Choroid Plexus Carcinoma – Market & Forecast
9.16 Retinoblastoma – Market & Forecast
9.17 Osteosarcoma – Market & Forecast
9.18 Ewing Sarcoma – Market & Forecast
9.19 Rhabdomyosarcoma – Market & Forecast
9.20 Other Sarcoma, High Grade – Market & Forecast
9.21 Other Sarcoma, Low Grade – Market & Forecast
9.22 Teratoma – Market & Forecast
9.23 Neuroblastoma – Market & Forecast
9.24 Ganglioglioma – Market & Forecast
9.25 Wilm’s Tumor – Market & Forecast
9.26 Carcinoma (non-CPC) – Market & Forecast
9.27 Lymphoma, Hodgkin’s – Market & Forecast
9.28 Lymphoma, Non-hodgkin’s – Market & Forecast
9.29 Leukemia – Market & Forecast
9.30 Desmoid – Market & Forecast
9.31 Melanoma – Market & Forecast
9.32 Pineal Parenchymal Tumor – Market & Forecast
9.33 Esthesioneuroblastoma – Market & Forecast
9.34 Angiofibroma – Market & Forecast
9.35 Extrarenal Rhabdoid Tumor – Market & Forecast
9.36 Others – Market & Forecast


10. Tumor Types USA Pediatrics Proton Therapy Patients (2010 – 2021)
10.1 Glioma, Low Grade – Patient Numbers & Forecast
10.2 Glioma, High Grade - Patient Numbers & Forecast
10.3 Medulloblastoma - Patient Numbers & Forecast
10.4 Ependymoma - Patient Numbers & Forecast
10.5 ATRT - Patient Numbers & Forecast
10.6 Germinoma, pure - Patient Numbers & Forecast
10.7 Germ Cell Tumor - Patient Numbers & Forecast
10.8 Craniopharyngioma - Patient Numbers & Forecast
10.9 PNET - Patient Numbers & Forecast
10.10 Pineoblastoma - Patient Numbers & Forecast
10.11 Chordoma/Chondrosarcoma - Patient Numbers & Forecast
10.12 Meningioma - Patient Numbers & Forecast
10.13 AVM - Patient Numbers & Forecast
10.14 Adenoma - Patient Numbers & Forecast
10.15 Choroid Plexus Carcinoma - Patient Numbers & Forecast
10.16 Retinoblastoma - Patient Numbers & Forecast
10.17 Osteosarcoma - Patient Numbers & Forecast
10.18 Ewing Sarcoma - Patient Numbers & Forecast
10.19 Rhabdomyosarcoma - Patient Numbers & Forecast
10.20 Other Sarcoma, High Grade - Patient Numbers & Forecast
10.21 Other Sarcoma, Low Grade - Patient Numbers & Forecast
10.22 Teratoma - Patient Numbers & Forecast
10.23 Neuroblastoma - Patient Numbers & Forecast
10.24 Ganglioglioma - Patient Numbers & Forecast
10.25 Wilm’s Tumor - Patient Numbers & Forecast
10.26 Carcinoma (non-CPC) - Patient Numbers & Forecast
10.27 Lymphoma, Hodgkin’s - Patient Numbers & Forecast
10.28 Lymphoma, Non-hodgkin’s - Patient Numbers & Forecast
10.29 Leukemia - Patient Numbers & Forecast
10.30 Desmoid - Patient Numbers & Forecast
10.31 Melanoma - Patient Numbers & Forecast
10.32 Pineal Parenchymal Tumor - Patient Numbers & Forecast
10.33 Esthesioneuroblastoma - Patient Numbers & Forecast
10.34 Angiofibroma - Patient Numbers & Forecast
10.35 Extrarenal Rhabdoid Tumor - Patient Numbers & Forecast
10.36 Others - Patient Numbers & Forecast


11. Europe Pediatric Proton Therapy Market (Actual & Potential)
11.1 Europe Pediatric Proton Therapy Market
11.2 Europe Pediatric Proton Therapy Potential Market


12. Europe Pediatric Proton Therapy Number of Patients (Actual & Potential)
12.1 Europe – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
12.2 Europe – Pediatric Patients with Proton Therapy Potential Numbers & Forecast


13. Europe Pediatric Proton Therapy Market Share by Countries


14. France Pediatric Proton Therapy Market – Actual & Potential Market
14.1 France – Pediatric Proton Therapy Market & Forecast
14.2 France – Potential Pediatric Proton Therapy Market



Comments

Post a Comment